查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1523173

肠外营养市场报告：2030 年趋势、预测与竞争分析

Parenteral Nutrition Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

肠外营养趋势与预测

预计到 2030 年，全球肠外营养市场预计将达到 73 亿美元，2024 年至 2030 年复合年增长率为 6.4%。该市场的主要驱动力是营养不良和慢性病的增加、消费者对临床营养意识的提高以及对单剂量肠外营养产品的日益偏好。全球肠外营养市场的未来前景广阔，碳水化合物、肠外脂肪乳剂、单剂量胺基酸溶液、微量元素以及维生素和矿物质市场充满机会。

肠外营养：按细分市场

研究包括按阶段类型、适应症、营养类型和地区对全球肠外营养的预测。

肠外营养市场洞察

Lucintel 预计，在预测期内，成人使用仍将占据很大一部分。

在该市场中，在预测期内，单剂量胺基酸溶液将继续成为最大的细分市场。

在预测期内，北美仍将是最大的地区。

常问问题

Q1.市场规模为：

A1. 到 2030 年，全球肠外营养市场预计将达到 73 亿美元。

Q2.市场成长预测是多少：

A2. 2024年至2030年，全球肠外营养市场预估复合年增率为6.4%。

Q3.影响市场成长的主要驱动因素是：

A3. 该市场的主要驱动力是营养不良和慢性病的增加、消费者对临床营养意识的增强以及对单剂量肠外营养产品的日益偏好。

Q4.市场的主要细分市场是：

A4.肠外营养市场的前景广阔，碳水化合物、肠外脂肪乳、单剂量胺基酸溶液、微量元素、维生素和矿物质市场都有机会。

Q5.市场的主要企业是：

A5. 主要肠外营养公司如下：

  • Baxter
  • Grifols
  • Allergan
  • Otsuka Pharmaceutical Factory
  • Actavis
  • B. Braun Melsungen
  • Fresenius Kabi
  • Vifor Pharma
  • Sichuan Kelun Pharmaceutical
  • Pfizer

Q6.未来最大的细分市场是什么？

A6.Lucintel 预计成人使用在预测期内仍将占据较大份额。

Q7. 未来五年预计哪些地区的市场成长最大？

A7. 在预测期内，北美仍将是最大的地区。

Q8. 可以客製化报告吗？

A8. 是的，Lucintel 提供 10% 的客製化服务，无需额外付费。

目录

第一章执行摘要

第二章全球肠外营养市场：市场动态

  • 简介、背景、分类
  • 供应链
  • 产业驱动因素与挑战

第三章 2018-2030年市场趋势及预测分析

  • 宏观经济趋势（2018-2023）与预测（2024-2030）
  • 全球肠外营养市场趋势（2018-2023）与预测（2024-2030）
  • 按阶段类型分類的全球肠外营养市场
    • 成人
    • 儿科的
  • 按适应症分類的全球肠外营养市场
    • 阿兹海默症
    • 营养不良
    • 癌症治疗
    • 糖尿病
    • 慢性肾臟病
    • 罕见疾病
    • 吞嚥困难
    • 其他的
  • 按营养类型分類的全球肠外营养市场
    • 碳水化合物
    • 肠外脂肪乳剂
    • 单剂量氨基酸溶液
    • 微量元素
    • 维生素和矿物质

第四章 2018-2030年区域市场趋势及预测分析

  • 全球肠外营养市场区域分布
  • 北美肠外营养市场
  • 欧洲肠外营养市场
  • 亚太肠外营养市场
  • 其他地区肠外营养市场

第五章 竞争分析

  • 产品系列分析
  • 业务整合
  • 波特五力分析

第六章 成长机会与策略分析

  • 成长机会分析
  • 全球肠外营养市场的新兴趋势
  • 战略分析
    • 新产品开发
    • 扩大全球肠外营养市场的能力
    • 全球肠外营养市场的合併、收购与合资企业
    • 认证和许可

第七章主要企业概况

  • Baxter
  • Grifols
  • Allergan
  • Otsuka Pharmaceutical Factory
  • Actavis
  • B. Braun Melsungen
  • Fresenius Kabi
  • Vifor Pharma
  • Sichuan Kelun Pharmaceutical
  • Pfizer
简介目录

Parenteral Nutrition Trends and Forecast

The future of the global parenteral nutrition market looks promising with opportunities in the carbohydrate, parenteral lipid emulsion, single dose amino acid solution, trace elements, and vitamin & mineral markets. The global parenteral nutrition market is expected to reach an estimated $7.3 billion by 2030 with a CAGR of 6.4% from 2024 to 2030. The major drivers for this market are rising cases of malnutrition and chronic diseases, increasing awareness about clinical nutrition among consumers, and growing preference for single-dose parenteral nutrition products.

A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.

Parenteral Nutrition by Segment

The study includes a forecast for the global parenteral nutrition by stage type, indication, nutrient type, and region.

Parenteral Nutrition Market by Stage Type [Shipment Analysis by Value from 2018 to 2030]:

  • Adult
  • Pediatrics

Parenteral Nutrition Market by Indication [Shipment Analysis by Value from 2018 to 2030]:

  • Alzheimer's
  • Nutrition Deficiency
  • Cancer Care
  • Diabetes
  • Chronic Kidney Diseases
  • Orphan Diseases
  • Dysphagia
  • Others

Parenteral Nutrition Market by Nutrient Type [Shipment Analysis by Value from 2018 to 2030]:

  • Carbohydrates
  • Parenteral Lipid Emulsion
  • Single Dose Amino Acid Solution
  • Trace Elements
  • Vitamins & Minerals

Parenteral Nutrition Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Parenteral Nutrition Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies parenteral nutrition companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the parenteral nutrition companies profiled in this report include-

  • Baxter
  • Grifols
  • Allergan
  • Otsuka Pharmaceutical Factory
  • Actavis
  • B. Braun Melsungen
  • Fresenius Kabi
  • Vifor Pharma
  • Sichuan Kelun Pharmaceutical
  • Pfizer

Parenteral Nutrition Market Insights

Lucintel forecasts that adult will remain larger segment over the forecast period.

Within this market, single dose amino acid solution will remain the largest segment over the forecast period.

North America will remain the largest region over the forecast period.

Features of the Global Parenteral Nutrition Market

Market Size Estimates: Parenteral nutrition market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Parenteral nutrition market size by stage type, indication, nutrient type, and region in terms of value ($B).

Regional Analysis: Parenteral nutrition market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different stage types, indications, nutrient types, and regions for the parenteral nutrition market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the parenteral nutrition market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the parenteral nutrition market size?

Answer: The global parenteral nutrition market is expected to reach an estimated $7.3 billion by 2030.

Q2. What is the growth forecast for parenteral nutrition market?

Answer: The global parenteral nutrition market is expected to grow with a CAGR of 6.4% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the parenteral nutrition market?

Answer: The major drivers for this market are rising cases of malnutrition and chronic diseases, increasing awareness about clinical nutrition among consumers, and growing preference for single-dose parenteral nutrition products.

Q4. What are the major segments for parenteral nutrition market?

Answer: The future of the parenteral nutrition market looks promising with opportunities in the carbohydrate, parenteral lipid emulsion, single dose amino acid solution, trace elements, and vitamin & mineral markets.

Q5. Who are the key parenteral nutrition market companies?

Answer: Some of the key parenteral nutrition companies are as follows:

  • Baxter
  • Grifols
  • Allergan
  • Otsuka Pharmaceutical Factory
  • Actavis
  • B. Braun Melsungen
  • Fresenius Kabi
  • Vifor Pharma
  • Sichuan Kelun Pharmaceutical
  • Pfizer

Q6. Which parenteral nutrition market segment will be the largest in future?

Answer: Lucintel forecasts that adult will remain larger segment over the forecast period.

Q7. In parenteral nutrition market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the parenteral nutrition market by stage type (adult and pediatrics), indication (Alzheimer's, nutrition deficiency, cancer care, diabetes, chronic kidney diseases, orphan diseases, dysphagia, and others), nutrient type (carbohydrates, parenteral lipid emulsion, single dose amino acid solution, trace elements, and vitamins & minerals), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Parenteral Nutrition Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Parenteral Nutrition Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Parenteral Nutrition Market by Stage Type
    • 3.3.1: Adult
    • 3.3.2: Pediatrics
  • 3.4: Global Parenteral Nutrition Market by Indication
    • 3.4.1: Alzheimer's
    • 3.4.2: Nutrition Deficiency
    • 3.4.3: Cancer Care
    • 3.4.4: Diabetes
    • 3.4.5: Chronic Kidney Diseases
    • 3.4.6: Orphan Diseases
    • 3.4.7: Dysphagia
    • 3.4.8: Others
  • 3.5: Global Parenteral Nutrition Market by Nutrient Type
    • 3.5.1: Carbohydrates
    • 3.5.2: Parenteral Lipid Emulsion
    • 3.5.3: Single Dose Amino Acid Solution
    • 3.5.4: Trace Elements
    • 3.5.5: Vitamins & Minerals

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Parenteral Nutrition Market by Region
  • 4.2: North American Parenteral Nutrition Market
    • 4.2.1: North American Parenteral Nutrition Market by Stage Type: Adult and Pediatrics
    • 4.2.2: North American Parenteral Nutrition Market by Nutrient Type: Carbohydrates, Parenteral Lipid Emulsion, Single Dose Amino Acid Solution, Trace Elements, and Vitamins & Minerals
  • 4.3: European Parenteral Nutrition Market
    • 4.3.1: European Parenteral Nutrition Market by Stage Type: Adult and Pediatrics
    • 4.3.2: European Parenteral Nutrition Market by Nutrient Type: Carbohydrates, Parenteral Lipid Emulsion, Single Dose Amino Acid Solution, Trace Elements, and Vitamins & Minerals
  • 4.4: APAC Parenteral Nutrition Market
    • 4.4.1: APAC Parenteral Nutrition Market by Stage Type: Adult and Pediatrics
    • 4.4.2: APAC Parenteral Nutrition Market by Nutrient Type: Carbohydrates, Parenteral Lipid Emulsion, Single Dose Amino Acid Solution, Trace Elements, and Vitamins & Minerals
  • 4.5: ROW Parenteral Nutrition Market
    • 4.5.1: ROW Parenteral Nutrition Market by Stage Type: Adult and Pediatrics
    • 4.5.2: ROW Parenteral Nutrition Market by Nutrient Type: Carbohydrates, Parenteral Lipid Emulsion, Single Dose Amino Acid Solution, Trace Elements, and Vitamins & Minerals

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Parenteral Nutrition Market by Stage Type
    • 6.1.2: Growth Opportunities for the Global Parenteral Nutrition Market by Indication
    • 6.1.3: Growth Opportunities for the Global Parenteral Nutrition Market by Nutrient Type
    • 6.1.4: Growth Opportunities for the Global Parenteral Nutrition Market by Region
  • 6.2: Emerging Trends in the Global Parenteral Nutrition Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Parenteral Nutrition Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Parenteral Nutrition Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Baxter
  • 7.2: Grifols
  • 7.3: Allergan
  • 7.4: Otsuka Pharmaceutical Factory
  • 7.5: Actavis
  • 7.6: B. Braun Melsungen
  • 7.7: Fresenius Kabi
  • 7.8: Vifor Pharma
  • 7.9: Sichuan Kelun Pharmaceutical
  • 7.10: Pfizer